Inotuzumab ozogamicin Intravenous and Insulin Aspart (Vials) (Fiasp)
Determining the interaction of Inotuzumab ozogamicin Intravenous and Insulin Aspart (Vials) (Fiasp) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Inotuzumab ozogamicin Intravenous-Insulin aspart and insulin aspart protamine
- Inotuzumab ozogamicin Intravenous-Insulin aspart and insulin degludec Subcutaneous
- Inotuzumab ozogamicin Intravenous-Insulin Aspart Injection
- Inotuzumab ozogamicin Intravenous-Insulin Aspart Protamine and Insulin Aspart
- Inotuzumab ozogamicin Intravenous-Insulin aspart protamine and insulin aspart Subcutaneous
- Inotuzumab ozogamicin Intravenous-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Insulin Aspart (Vials) (Fiasp)-Inova
- Insulin Aspart (Vials) (Fiasp)-Inova 4/1 topical
- Insulin Aspart (Vials) (Fiasp)-Inova 8/2 topical
- Insulin Aspart (Vials) (Fiasp)-Inova ACT
- Insulin Aspart (Vials) (Fiasp)-Inrebic
- Insulin Aspart (Vials) (Fiasp)-Inspra